Sulfur Hexafluoride Lipid-type A Microspheres Patent Expiration

Sulfur Hexafluoride Lipid-Type A Microspheres is Used for characterizing focal liver lesions with ultrasound in both adult and pediatric patients. It was first introduced by Bracco Diagnostics Inc in its drug Lumason on Oct 15, 2014.


Sulfur Hexafluoride Lipid-type A Microspheres Patents

Given below is the list of patents protecting Sulfur Hexafluoride Lipid-type A Microspheres, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lumason US10232061 Freeze-dried formulation for gas-filled microvesicles Jul 06, 2038 Bracco
Lumason US10335502 Freeze-dried formulation for gas-filled microvesicles Jul 06, 2038 Bracco
Lumason US11723869 Freeze-dried product and gas-filled microvesicles suspension May 15, 2039 Bracco
Lumason US5686060 Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography Nov 11, 2019

(Expired)

Bracco